(Q35889626)

English

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67.

scientific article published on 30 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67. (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1 reference

based on heuristic

inferred from title

Tsutomu Takashima

3

object named as

Tsutomu Takashima

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

Shinichiro Kashiwagi

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Masakazu Yashiro

2

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Naoki Aomatsu

4

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Katsumi Ikeda

5

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Yoshinari Ogawa

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Tetsuro Ishikawa

7

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Kosei Hirakawa

8

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

publication date

30 November 2011

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Breast Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

13

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

R122

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Significance of E-cadherin expression in triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Metastatic behavior of breast cancer subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Ki67 in breast cancer: prognostic and predictive potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Adjuvant therapy of triple negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Triple-negative breast cancer--current status and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Prognostic markers in triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

E-cadherin-dependent intercellular adhesion enhances chemoresistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Revision of breast cancer staging: the 6th edition of the TNM Classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Molecular portraits of human breast tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

p53 protein overexpression and chemosensitivity in breast cancer. Institut Gustave-Roussy Breast Cancer Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

11 July 2018

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

Neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers.

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

Role of morphogenetic factors in metastasis of mammary carcinoma cells.

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival.

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy.

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast Cancer.

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

p53 as a specific prognostic factor in triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast.

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

A pooled analysis of bone marrow micrometastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes

1 reference

https://api.crossref.org/works/10.1186%2FBCR3068

21 January 2018

Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

24 September 2018

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326564

24 September 2018

Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22126395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22126395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22126395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22126395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22126395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/BCR3068

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35889626&oldid=2197923195"